142 related articles for article (PubMed ID: 2609718)
1. [The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
Mauser M; Voelker W; Ickrath O; Hoffmeister HM; Karsch KR
Z Kardiol; 1989 Nov; 78(11):726-31. PubMed ID: 2609718
[TBL] [Abstract][Full Text] [Related]
2. [Neither propranolol nor the vasodilating beta-blocker carvedilol have a direct effect on coronary resistance vessels].
Sievert H; Schmidt T; Frey G; Schräder R; van der Does R; Kaltenbach M; Kober G
Z Kardiol; 1991 Jan; 80(1):15-9. PubMed ID: 1674632
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
Wendt T
Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
[TBL] [Abstract][Full Text] [Related]
5. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
6. [Isradipine (PN 200-110), a new dihydropyridine calcium antagonist with slight negative inotropic properties in comparison with nifedipine].
Mauser M; Voelker W; Karsch KR
Z Kardiol; 1988 Jun; 77(6):373-7. PubMed ID: 2975095
[TBL] [Abstract][Full Text] [Related]
7. Changes in haemodynamics and left ventricular function during intravenous nifedipine infusion with and without additional propranolol in patients with coronary artery disease. A randomized, placebo controlled trial.
Mauser M; Voelker W; Roser D; Karsch KR; Seipel L
Eur J Clin Pharmacol; 1987; 33(4):345-8. PubMed ID: 3327697
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
9. Coronary hemodynamic and metabolic effects of nifedipine in patients with coronary artery disease treated with beta-blocking drugs.
Schanzenbächer P; Göttfert G; Liebau G; Kochsiek K
Am J Cardiol; 1985 Jan; 55(1):33-6. PubMed ID: 3966396
[TBL] [Abstract][Full Text] [Related]
10. Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.
DasGupta P; Lahiri A
Clin Investig; 1992; 70 Suppl 1():S98-104. PubMed ID: 1350492
[TBL] [Abstract][Full Text] [Related]
11. Influence of carvedilol and propranolol on coronary blood flow.
Sievert H; Frey G; Schräder R; Schmidt T; van der Does R; Kaltenbach M; Kober G
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S122-4. PubMed ID: 1974502
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on left ventricular function and arrhythmias during repeated short-time myocardial ischemia in experimental pigs.
Höher M; Friedrich M; Sommer T; Marten A; Ehmer B; Hombach V; Hirche H
Z Kardiol; 1989; 78 Suppl 3():7-15. PubMed ID: 2573214
[TBL] [Abstract][Full Text] [Related]
13. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.
Pouleur H; Etienne J; Van Mechelen H; Van Eyll C; Charlier AA; Brasseur LA; Rousseau MF
Postgrad Med J; 1984; 60 Suppl 4():23-8. PubMed ID: 6527976
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease].
Mauser M; Voelker W; Ickrath O; Karsch KR
Z Kardiol; 1993 Jan; 82(1):17-27. PubMed ID: 8470415
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
16. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
DasGupta P; Broadhurst P; Lahiri A
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV
Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802
[TBL] [Abstract][Full Text] [Related]
19. Direct cardiac and peripheral vascular effects of intracoronary and intravenous nifedipine.
Terris S; Bourdillon PD; Cheng DT; Pitt B
Am J Cardiol; 1986 Jul; 58(1):25-30. PubMed ID: 3728327
[TBL] [Abstract][Full Text] [Related]
20. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
